000			01932 a2200601 4500
005			20250517121730.0
264		0	_c20170117
008			201701s 0 0 eng d
022			_a1421-9875
024	7		_a10.1159/000448823 _2doi
040			_aNLM _beng _cNLM
100	1		_aSugimoto, Kayo
245	0	0	_aEfficacy and Safety of Sofosbuvir Plus Ribavirin Treatment for Patients with Chronic Hepatitis C Genotype 2. _h[electronic resource]
260			_bDigestive diseases (Basel, Switzerland) _c
300			_a627-631 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article
650	0	4	_aAdult
650	0	4	_aAge Factors
650	0	4	_aAged
650	0	4	_aAntiviral Agents _xadministration & dosage
650	0	4	_aDrug Carriers
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aGenotype
650	0	4	_aHemoglobins _xanalysis
650	0	4	_aHepacivirus _xgenetics
650	0	4	_aHepatitis C, Chronic _xdrug therapy
650	0	4	_aHumans
650	0	4	_aInterferons _xtherapeutic use
650	0	4	_aLiver Cirrhosis _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPolyethylene Glycols
650	0	4	_aPyrophosphatases _xgenetics
650	0	4	_aRibavirin _xadministration & dosage
650	0	4	_aSafety
650	0	4	_aSofosbuvir _xadministration & dosage
650	0	4	_aTreatment Outcome
650	0	4	_aInosine Triphosphatase
700	1		_aKim, Soo Ki
700	1		_aKim, Soo Ryang
700	1		_aKobayashi, Mana
700	1		_aKato, Airi
700	1		_aMorimoto, Eri
700	1		_aImoto, Susumu
700	1		_aKim, Chi Wan
700	1		_aTanaka, Yasuhito
700	1		_aKudo, Masatoshi
700	1		_aYano, Yoshihiko
700	1		_aHayashi, Yoshitake
773	0		_tDigestive diseases (Basel, Switzerland) _gvol. 34 _gno. 6 _gp. 627-631
856	4	0	_uhttps://doi.org/10.1159/000448823 _zAvailable from publisher's website
999			_c26523836 _d26523836